📰 Exsight Ventures News
Exsight Ventures News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exsight Ventures. Real-time updates on events, politics, business and more.
May 8, 2023
Additional data from the STORM study demonstrate vision quality to be a major driver of the patient decision to undergo surgerySAN DIEGO--(BUSINESS WIRE)--Trefoil Therapeutics, a clinical-stage biotechnology company focused on developing novel new therapeutic agents to treat corneal diseases, today announced that TT...
March 14, 2023
Northern Ireland tech companies are performing well in terms of investment say Catalyst, but another recent report said women founders are underrepresented.
December 5, 2022
Re-Vana Therapeutics develops products to improve the delivery of drugs for chronic eye disease.
December 5, 2022
Re-Vana Therapeutics To Research Sight-Threatening Eye Disease
December 2, 2022
Re-Vana Therapeutics develops products to improve the delivery of drugs for chronic eye disease.
December 1, 2022
Re-Vana Therapeutics is developing technology that can provide sustained drug delivery for up to six months for people with eye diseases.
November 30, 2022
/PRNewswire/ -- Re-Vana Therapeutics Ltd, a privately-held specialty drug delivery company developing sustained-release therapeutics for the treatment of...
November 30, 2022
/PRNewswire/ -- Re-Vana Therapeutics Ltd, a privately-held specialty drug delivery company developing sustained-release therapeutics for the treatment of...
November 30, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
November 10, 2022
/PRNewswire/ -- The global ophthalmic drugs market size is expected to reach USD 65.6 billion by 2030, garnering a CAGR of 7.7% from 2022 to 2030, according to...